| |
| |
|
| Insider
Information: |
Demaree John |
| Relationship: |
Chief Commercial Officer |
| City: |
Research Triangle Park |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
29,245 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$47,597 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,245 |
|
|
| Total
Value |
$47,597 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -35.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
G1 Therapeutics Inc |
GTHX |
|
2018-12-10 |
5,250 |
2018-12-10 |
0 |
Premium* |
|
|
Karyopharm Therapeutics Inc. |
KPTI |
Chief Commercial Officer |
2021-02-25 |
23,995 |
2020-08-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
3 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
3 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
